Brammer Bio provides viral vector development and manufacturing services with over 20 years of experience in the industry, offering process and analytical development, clinical and commercial manufacturing, and fill-finish services.

Brammer Bio

WELL Health.ai develops and invests in AI-enabled tools and technologies for healthcare providers, aiming to positively impact health outcomes.

WELL Health.ai

Aragen Life Sciences Ltd. provides CDMO services and R&D drug development processes, specializing in both small and large molecules.

Metric
Company Name	Brammer Bio	WELL Health.ai	Aragen Life Sciences Ltd.
Symbol
MSH ID	COM:BRAMMERBIO	AI:WELLHEALTH	COM:GVKBIO
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology	Healthcare Technology	Biotechnology
Country	US	CA	IN
Stage		Seed
Employee Count
Website	brammerbio.com	wellhealth.ai	gvkbio.com
LinkedIn		wellhealthtechnologiescorp
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		1
Web Traffic Growth		-0.99
Valuation
Raised Capital		1.20M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:BRAMMERBIO

Brammer Bio

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue